Montana § 45-9-104 Fraudulently Obtaining Dangerous Drugs

Montana Statutes

§ 45-9-104 — Fraudulently Obtaining Dangerous Drugs

Montana § 45-9-104

Title 45CRIMES

Ch. 9DANGEROUS DRUGS

Part 1Offenses Involving Dangerous Drugs

This text of Montana § 45-9-104 (Fraudulently Obtaining Dangerous Drugs) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 45-9-104 (2026).

Text

45-9-104 . Fraudulently obtaining dangerous drugs. A person commits the offense of fraudulently obtaining dangerous drugs if the person obtains or attempts to obtain a dangerous drug, as defined in 50-32-101 , by:

(1)fraud, deceit, misrepresentation, or subterfuge;

(2)falsely assuming the title of or representing that the person is a manufacturer, wholesaler, practitioner, pharmacist, owner of a pharmacy, or other person authorized to possess dangerous drugs;

(3)the use of a forged, altered, or fictitious prescription;

(4)the use of a false name or a false address on a prescription;

(5)the concealment of a material fact;

(6)knowingly or purposefully failing to disclose to a practitioner, as defined in 50-32-101 , that the person has received the same or a similar dangerous drug or pr

Free access — add to your briefcase to read the full text and ask questions with AI

45-9-104 . Fraudulently obtaining dangerous drugs. A person commits the offense of fraudulently obtaining dangerous drugs if the person obtains or attempts to obtain a dangerous drug, as defined in 50-32-101 , by:
(1) fraud, deceit, misrepresentation, or subterfuge;
(2) falsely assuming the title of or representing that the person is a manufacturer, wholesaler, practitioner, pharmacist, owner of a pharmacy, or other person authorized to possess dangerous drugs;
(3) the use of a forged, altered, or fictitious prescription;
(4) the use of a false name or a false address on a prescription;
(5) the concealment of a material fact;
(6) knowingly or purposefully failing to disclose to a practitioner, as defined in 50-32-101 , that the person has received the same or a similar dangerous drug or prescription for a dangerous drug from another source within the prior 30 days; or
(7) knowingly or purposefully communicating false or incomplete information to a practitioner with the intent to procure the administration of or a prescription for a dangerous drug. A communication of this information for the purpose provided in this subsection is not a privileged communication.